By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Small Business Innovation Research (SBIR) 

Regional Area      U.S.A.
Phone: 800-382-4634 Fax: 800-462-4128


Company News
Bioaxone Biosciences Announces NIH/SBIR Fast Track Grant To Develop BA-1049 For Treatment Of Cerebral Cavernous Malformation/Angioma 2/8/2016 12:24:20 PM
Nuviant Medical Awarded $175k NIH SBIR Grant To Develop Treatment For Dysphagia 12/16/2015 6:19:29 AM
Hillhurst Biopharmaceuticals Receives SBIR Funding For Development Of HBI-002 As A Cytoprotective Therapeutic In Acute Cerebral Injury 12/2/2015 6:34:57 AM
CytoSorbents, Inc. To Advance HemoDefend Towards Commercialization With $1.5 Million Phase II SBIR Contract From NHLBI/NIH 10/27/2015 7:53:58 AM
AxioMx Awarded SBIR Grant For Rapid scFv-to-IgG Conversion Development 10/13/2015 12:06:34 PM
Altor BioScience Corporation Announces National Cancer Institute Phase II SBIR Grant Award And Publication Supporting Ongoing Clinical Trial Of IL-15 Super Agonist ALT-803 In Combination With Anti-CD20 Antibody Therapy For Relapsed / Refractory Non-Hodgkin Lymphoma 10/6/2015 10:58:22 AM
Cellectar Biosciences  (NVLT) Awarded $2.3 Million National Cancer Institute Fast-Track SBIR Grant To Advance Phospholipid Drug Conjugate (PDC) Delivery Platform 10/1/2015 7:29:15 AM
Protagonist Therapeutics Receives SBIR Funding For Oral IL-23 Receptor Antagonists For Treatment Of Inflammatory Bowel Diseases 9/24/2015 11:09:45 AM
CalAsia Pharmaceuticals, Inc. Announces Continuation Of Funding Of NIH SBIR Phase I Grant And Key Appointments To Management And Scientific Advisory Board 9/21/2015 12:36:42 PM
Navidea (NAVB) Awarded $1.8M Fast Track NIH SBIR Grant For Evaluation Of A Manocept Agent In Kaposi‚Äôs Sarcoma 9/3/2015 10:46:07 AM